Sort
30,917 grants matching “tumor microenvironment”
Project 2: Reversing STING-mediated immunosuppression in LKB1-mutant lung adenocarcinoma
$394,856Haian Fu · Emory University · P01 · FY2022 · CA
Regulation of Tumor Microenvironment in Cancer
$394,854Dmitry Isaac Gabrilovich · Wistar Institute · R01 · FY2014 · CA
Validating the eCyPA/CD147 signaling complex for myeloma therapy
$394,823Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Validating the eCyPA/CD147 signaling complex for myeloma therapy
$394,823Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Mechanochemical Effects on Tumor Cell Signaling, Adhersion and Migration
$394,799Konstantinos Konstantopoulos · Johns Hopkins University · U54 · FY2013 · CA
S100A4 mediated immune suppression in GBM
$394,788Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2025 · NS
Characterization of the interaction between inflammation and cancer progression
$394,722Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Tumor models for the study of inflammation and oncogenesis
$394,722Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Enhancing antitumor efficacy by intratumoral delivering LAIR1 inhibitory signaling
$394,687Jianping Huang · University Of Florida · R21 · FY2025 · CA
Defining the Function of Age-Related Epimutation in Intestinal Tumorigenesis
$394,591Lanlan Shen · Baylor College Of Medicine · R01 · FY2025 · CA
Combinational Immunotherapy Targeting the Melanoma-Associated Vasculature
$394,575Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · CA
Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers
$394,548Edwin Manuel · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
$394,548Valeri Vasioukhin · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Fatty acids and their receptors-mediated tumor metastasis and progression
$394,548Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Fatty acids and their receptors-mediated tumor metastasis and progression
$394,548Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer
$394,548Valeri Vasioukhin · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
N-cadherin in Extraskeletal Osteolineage Cells Modulates Tumor Growth
$394,533Roberto Civitelli · Washington University · R01 · FY2020 · CA
LAT1 as a Novel Therapeutic Target in Colorectal Cancer
$394,532Subbaya Subramanian · University Of Minnesota · R21 · FY2025 · CA
Targeting CXCR2 axis in Pancreatic Cancer
$394,508Rakesh K Singh · University Of Nebraska Medical Center · R01 · FY2022 · CA
Targeting Lag-3 and PD -1 in Myeloid Cells of GBM
$394,429Michael Lim · Stanford University · R01 · FY2025 · NS
Theranostic nanoparticles for detection and treatment of pancreatic cancer
$394,421Lacey R McNally · Wake Forest University Health Sciences · R01 · FY2017 · EB
A First-in-Class FAP-activated Protoxin to disrupt the Tumor-Stroma Parasitic Cycle fueling lethal Prostate Cancer Progression
$394,398William Nathaniel Brennen · Johns Hopkins University · R01 · FY2024 · CA
Cellular crosstalk in the hematopoietic microenvironment
$394,381Daniel Lucas · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · HL
Developmental origins of cancer
$394,362Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Project 1 - Molecular Genetics of Human Papillomavirus Infection and Oncogenesis
$394,350Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2022 · CA